期刊文献+

肺炎衣原体与冠心病关系的研究 被引量:2

Relationship between chlamydia pneumoniae and coronary atherosclerotic heart disease
暂未订购
导出
摘要 目的:探讨肺炎衣原体(TWAR)与冠状动脉粥样硬化心脏病(CHD)之间的关系。方法:采用多聚合酶链反应(PCR)技术对200例冠心病和180例非冠心病患者进行全血标本肺炎衣原体DNA检测。结果:冠心病组肺炎衣原体DNA阳性率为57.5%,对照组为21.1%,两组有显著性差异(P<0.01);另外,在冠心病组,肺炎衣原体DNA阳性率:男性显著高于女性(P<0.01);吸烟患者显著高于非吸烟患者(P<0.01);急性心梗较其他类型冠心病相比有显著性差异(P<0.01)。结论:肺炎衣原体感染与冠心病存在密切关系,可能是冠心病发生、发展的因素之一。 Objective: To investigate the relationship between chlamydia pneumoniae (TWAR) and coronary atherosclerotic heart dlsease(CHD) . Methods : By means of polymerase chain reaction(PCR), TWAR nucleic acid were detected in 200 patients with CHD and 180 control subjects. Results:The positlvity rate of TWAR-DNA was 57.5%(115/200) in the patient group and 21. 1%(38/180) in the control group, showing obvious difference between the two groups(P 〈0. 01). In addition, the positivity rate of TWAR-DNA was 64. 8%, 71. 6%, 73.2% in male , smoking or AMI patients with CHD and 26.3%, 17.3%, 51.3% in the control patients with CHD, respectively, which shows significant difference (P〈0. 01, P 〈0. 01, P 〈0. 01). Conclusion: TWAR infection is closely connected with CHD, and may be one of the risk factors in CHD mechanisms.
出处 《陕西医学杂志》 CAS 北大核心 2008年第1期62-64,共3页 Shaanxi Medical Journal
基金 河北省科技厅指导项目(No 002761107)
关键词 冠状动脉疾病/病因学 冠状动脉疾病/血液 衣原体 肺炎/血液 聚合酶链反应 Coronary disease/etiology Coronary disease/blood Chlamydophila pneumoniae/ blood Polymerase chain reaction
  • 相关文献

参考文献8

  • 1Saikku P,Leinonen M,Mattila K,et al.Serological evidence of an association of a novel chlamydia,TWAR,with chronic coronary heart disease and acute myocardial infarction.Lancet,1988,2(8618):983-985.
  • 2Sessa R,Pietro MD,Santino I,et al.Chlamydia pneumoniae infection and atherosclerotic coronary disease.Am Heart J,1999,137(6):1116-1119.
  • 3Kuo CC,Shor A,Campbell LA,et al.Demonstration of chlamydia pneumoniae in atherosclerotic lesions of cornary arteries.J Infect Dis,1993,167(4):841.
  • 4Gupta S,Leatham EW,Carrington D,et al.Elevated chlamydia pneumoniae antibodies,cardiovascular events,and azithromycin in male survivors of myocardial infarction.Circulation,1997,96 (2):404-407.
  • 5Gaydos CA,Fowler CL,Gill VJ,et al.Dection of chlamydia pneumoniae by polymerase chain reactionenzyme immunoassay in an immocompnimised population.Clinical Infectious Disease,1993,17 (3):718-723.
  • 6Gurfinkel E,Bozovich G,Daroca A,et al.Randomized trial of roxithromycin in non-Q-wave coronary syndromes:ROXIS pilot study.Lancet,1997,350(2):404-407.
  • 7Campbell LA,Moazed TC,Kuo CC,et al.Mouse models of atherosclerosis and chlamydia pneumoniae.Proc Tird Eur Soc Ghlam Rcs,1996,3 (1):106.
  • 8Weiss SM,Roblin PM,Gaydos CA,et al.Failure to detect chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.J Infect Dis,1996,173(5):957-963.

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部